scispace - formally typeset
Search or ask a question
Institution

Torrey Pines Institute for Molecular Studies

NonprofitSan Diego, California, United States
About: Torrey Pines Institute for Molecular Studies is a nonprofit organization based out in San Diego, California, United States. It is known for research contribution in the topics: Antigen & T cell. The organization has 2323 authors who have published 2217 publications receiving 112618 citations.


Papers
More filters
Journal ArticleDOI
TL;DR: The first report of the occurrence of EACMV in West Africa is reported, indicating the geminiviruses causing CMD in Africa are more widely distributed than previously reported.
Abstract: Cassava mosaic disease (CMD) occurs in all cassava-growing regions of Africa, India, and Sri Lanka. Characterized by mosaic and distortion of cassava leaves and reduced plant growth, causing high yield losses, CMD is caused by geminiviruses (genus Begomovirus, family Geminiviridae) transmitted through infected cuttings or by the whitefly, Bemisia tabaci. Three such geminiviruses have been described: African cassava mosaic virus (ACMV) occurs in most of the cassava-producing zones of Africa; East African cassava mosaic virus (EACMV) in East Africa; and Indian cassava mosaic virus (ICMV) in the Indian subcontinent (1). The two components of ACMV and ICMV genomes, DNA-A and DNA-B, have been sequenced; only DNA-A of EACMV has been identified and sequenced. Variations in symptom expression and severity within the same cassava variety have been observed in Cameroon. To determine the nature of the virus species inducing such variations, 50 samples were collected from CMD-infected plants in the savannah and rainf...

35 citations

Journal ArticleDOI
TL;DR: It is reported that CRAM is expressed by human peripheral blood and bone marrow B cells, and by different B‐cell lines dependent on the B‐ cell maturation stage, and that it is potentially involved in immunomodulatory functions together with CCL5.
Abstract: Chemokines orchestrate the organization of leucocyte recruitment during inflammation and homeostasis. Despite growing knowledge of chemokine receptors, some orphan chemokine receptors are still not characterized. The gene CCRL2 encodes such a receptor that exists in two splice variants, CRAM-A and CRAM-B. Here, we report that CRAM is expressed by human peripheral blood and bone marrow B cells, and by different B-cell lines dependent on the B-cell maturation stage. Intriguingly, CRAM surface expression on the pre-B-cell lines Nalm6 and G2 is specifically upregulated in response to the inflammatory chemokine CCL5 (RANTES), a chemokine that is well known to play an important role in modulating immune responses. Although Nalm6 cells do not express any of the known CCL5 binding receptors, extracellular signal-regulated kinases 1 and 2 (ERK1/2) are phosphorylated upon CCL5 stimulation, suggesting a direct effect of CCL5 through the CRAM receptor. However, no calcium mobilization or migratory responses upon CCL5 stimulation are induced in B-cell lines or in transfected cells. Also, ERK1/2 phosphorylation cannot be inhibited by pertussis toxin, suggesting that CRAM does not couple to Gi proteins. Our results describe the expression of a novel, non-classical chemokine receptor on B cells that is potentially involved in immunomodulatory functions together with CCL5.

35 citations

Journal ArticleDOI
TL;DR: Challenges remain in the application of gene therapy techniques to skin substitutes, both the control of transgene expression and in the selection of suitable genes to transfect, and a challenge that may be diminishing is the importance of acute rejection of allogeneic tissue-engineered skin substitutes.
Abstract: The last two years have seen new tissue-engineered skin substitutes come onto the market and begin to resolve the various roles to which each is best suited. It is becoming evident that some of the very expensive cell-based products have cost-benefit advantage despite their high price and are valuable within the restricted applications for which they are intended. The use of skin substitutes for testing purposes has extended from epidermal keratinocytes to other integumentary epithelia and into preparations containing multiple cell types in which reactions resulting from paracrine interactions can be examined. Challenges remain in the application of gene therapy techniques to skin substitutes, both the control of transgene expression and in the selection of suitable genes to transfect. A coming challenge is the production of tissue-engineered products without the use of animal products other than human cells. A challenge that may be diminishing is the importance of acute rejection of allogeneic tissue-eng...

35 citations

Journal ArticleDOI
TL;DR: In this paper, the synthesis of a photoaffinity probe for EGFR was described, which was shown to have an efficiency of 34% and to be competitive with the EGFR inhibitors PP2 and AG1478.

34 citations

Journal ArticleDOI
TL;DR: Subjects and anatomical location are shown to be significantly different for the ability to recover RNA by tape stripping and it is hypothesize that RNA recovered by tape strip is not derived from corneocytes but from cells associated with the stratum corneum.

34 citations


Authors

Showing all 2327 results

NameH-indexPapersCitations
Eric J. Topol1931373151025
John R. Yates1771036129029
George F. Koob171935112521
Ian A. Wilson15897198221
Peter G. Schultz15689389716
Gerald M. Edelman14754569091
Floyd E. Bloom13961672641
Stuart A. Lipton13448871297
Benjamin F. Cravatt13166661932
Chi-Huey Wong129122066349
Klaus Ley12949557964
Nicholas J. Schork12558762131
Michael Andreeff11795954734
Susan L. McElroy11757044992
Peter E. Wright11544455388
Network Information
Related Institutions (5)
Scripps Research Institute
32.8K papers, 2.9M citations

94% related

Merck & Co.
48K papers, 1.9M citations

93% related

GlaxoSmithKline
21.1K papers, 1.1M citations

92% related

Novartis
50.5K papers, 1.9M citations

92% related

Genentech
17.1K papers, 1.4M citations

91% related

Performance
Metrics
No. of papers from the Institution in previous years
YearPapers
20235
202210
202153
202060
201950
201842